Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
AP4S1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINC00606 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RASAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00672 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MC1R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC102725207 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KATNAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC2A6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GREB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR8071-2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAS7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SBF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOM1L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on